NCT06675448View on ClinicalTrials.gov

In Search of Best Practices for Patients With Heart Failure and Secondary Mitral Regurgitation: An Evaluation of the Inova Heart Failure Treatment Algorithm

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

January 28, 2021

Primary Completion Date

September 10, 2029

Study Completion Date

September 10, 2030

Conditions
Mitral RegurgitationValvular Heart DiseaseHeart Failure
Interventions
DEVICE

MitraClip

Participants will undergo the Mitraclip procedure according to current standards of practice

OTHER

Moderate MR

Patients who present with moderate MR (Mitral regurgitation) will serve also as an internal control against which the outcomes of Mitraclip treated patients)

Trial Locations (1)

22042

RECRUITING

Inova Fairfax Medical Campus, Falls Church

Sponsors
All Listed Sponsors
lead

Inova Health Care Services

OTHER